期刊文献+

非酒精性脂肪性肝病与代谢综合征相关性的临床研究 被引量:2

Non-alcoholic fatty liver disease and metabolic syndrome
下载PDF
导出
摘要 目的分析非酒精性脂肪性肝病与代谢综合征的关系。方法按住院顺序选择有随访资料病例共185例,将其分为四组(单纯脂肪肝组、单纯肥胖组、脂肪肝+肥胖组、正常对照组),在基线水平对四组出现代谢综合征情况进行横向比较。其次,在随访后再次对四组出现代谢综合征情况进行组内、组间比较。结果随访结束时,单纯脂肪肝组代谢综合征发病率明显高于正常对照组(P<0.05)。结论非酒精性脂肪性肝病促进代谢综合征的发生,且不依赖于肥胖。 Objective To explore the possible relation between NAFLD and MS. Methods Collecting 185subjects with follow - up data, We divided all participants into four groups : First, we contrasted the incidence rates of MS among all the groups. Then, after following up, we contrasted the incidence above - mentioned index among four groups. Results At the end of follow - up, the incidence rates of MS in fatty liver group were significantly higher than those in control group, independent of obesity. Conclusion NAFLD might promote the development of MS.
出处 《临床肝胆病杂志》 CAS 2009年第4期269-271,共3页 Journal of Clinical Hepatology
关键词 非酒精性脂肪性肝病 代谢综合征 non- alcoholic fatty liver disease metabolic syndrome
  • 相关文献

参考文献9

  • 1Angulo P. Nonalcoholic fatty liver disease [ J ]. N Engl J Med,2003, 346: 1221 - 1231.
  • 2Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease : an agenda for clinical research [ J ]. Hepatology, 2002, 35 : 746 - 752.
  • 3Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease [J]. Gastroerterology, 2002, 122 (6) : 1649- 1657.
  • 4Angulo P. Nonalcoholic fatty liverdisease [ J ]. N Engl J Med, 2002, 346 (16) : 1221-1231.
  • 5范建高.第二讲 非酒精性脂肪肝的临床流行病学研究[J].中华消化杂志,2002,22(2):106-107. 被引量:284
  • 6Brunt EM. Nonalcohohc steatohepatitis [ J ]. Semin Liver Dis, 2004, 24 (1) : 3-20.
  • 7Day CP. Pathogenesis of steatohepatitis. Best practice and research [J]. Clin Gastroenterol, 2005, 16:663 -782.
  • 8Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatter liver disease : a feature of themetabolic syndrome [ J]. Diabetes, 2001, 50 (8) : 1844-1850.
  • 9Bloom garden ZT. Definitions of the insulin resistance syndrome: the 1 st World Congress on the Insulin Resistance Syndrome [ J ]. Diabetes Care, 2005, 27:824-830.

共引文献283

同被引文献33

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2张自然,李良平.瘦素,Ghrelin与非酒精性脂肪肝[J].胃肠病学和肝病学杂志,2006,15(6):637-640. 被引量:2
  • 3张立新,薛峰,赵爱云,王丽娜,林维红.海星中皂苷总含量测定方法的研究[J].食品科学,2007,28(1):243-246. 被引量:8
  • 4KOJIMA M, HOSODA H, DATE Y, et al. Ghrelin is a growth - hormone - releasing acylated peptide from stomach[J] . Nature, 1999,402(6762): 656 -660.
  • 5CUMMINGS DE, PUMELLJO, FRAY RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans[J]. Diabetes, 2001,50(8): 1714 -1719.
  • 6TAKAYA K, ARIYASU H, KANAMOTO N, et al. Ghrelin strongly stimulates growth hormone release in humans[J].J Clin Endocrinol Metab, 2000, 85( 12): 4908 -4911.
  • 7DAVIESJS, KOTOKORPI P, ECCLES SR, et al. Ghrelin induces abdominal obesity via GHS - R dependent lipid retention[J]. Mol Endocrinol, 2009, 23 (6) : 914 -924.
  • 8THEANDER -CARRILLO C, WIEDMER P, ROSE PC, et al. Ghrelin action in the brain controls adipocyte metabolism] J}. Clin Invest, 2006,116 (7): 1983 -1993.
  • 9YASUDA T, MASAKI T, KAKUMA T, et al. Centrallyadimin-istered Ghrelin suppresses sympahtathetic nerve activity in brown adiposetissue of rats[J]. Neurosci Lett, 2003, 349 (2): 75 -78.
  • 10KIM MS, YCON CY,JANG PG, et al. Themitogenic and anti - apoptoticactions of Ghrelin in 3T3 - L 1 adipocytes[J]. Mol Endocrinol, 2004, 18 (9) : 2291 -2301.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部